Smith & Nephew plc (ADR)  

(Public, NYSE:SNN)   Watch this stock  
Find more results for SNN
31.42
-0.29 (-0.91%)
After Hours: 31.42 0.00 (0.00%)
Mar 28, 4:02PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 31.37 - 31.63
52 week 26.97 - 35.38
Open 31.57
Vol / Avg. 378,407.00/509,962.00
Mkt cap 13.54B
P/E 17.89
Div/yield 0.37/3.17
EPS 1.76
Shares 874.94M
Beta 0.81
Inst. own 3%
Feb 9, 2017
Q4 2016 Smith & Nephew PLC Earnings Call
Feb 9, 2017
Q4 2016 Smith & Nephew PLC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 23.20% 16.79%
Operating margin 32.89% 24.14%
EBITD margin - 28.27%
Return on average assets 14.59% 10.81%
Return on average equity 27.41% 19.79%
Employees 15,584 -
CDP Score - 98 C

Address

15 Adam Street
LONDON, WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 58
Bio & Compensation  - Reuters
Graham Baker Chief Financial Officer, Executive Director
Age: 48
Bio & Compensation  - Reuters
Rodrigo Bianchi President, Asia Pacific and Emerging Markets
Age: 57
Bio & Compensation  - Reuters
Brad Cannon President, Europe and Canada
Age: 49
Bio & Compensation  - Reuters
Vasant Padmanabhan Ph.D. President - Research & Development
Age: 50
Bio & Compensation  - Reuters
Cyrille Petit Chief Corporate Development Officer, President - Global Business Services
Age: 46
Bio & Compensation  - Reuters
Matthew R. Stober President - Global Operations
Age: 49
Bio & Compensation  - Reuters
Glenn S. Warner President, US
Age: 54
Bio & Compensation  - Reuters
Elga Lohler Chief Human Resource Officer
Age: 49
Bio & Compensation  - Reuters
John W. Campo Chief Legal Officer
Age: 62
Bio & Compensation  - Reuters